Browse Category

Investment Insights News 11 November 2025 - 16 November 2025

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited heads into Monday’s open with investors still digesting a tough few months: a surprise guidance downgrade and delayed vaccines demerger at the late‑October AGM, followed by a steady drumbeat of daily buy‑back notices last week. Below is a
Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti Computing (RGTI) Stock: Q3 2025 Shock, Insider Selling and a High‑Risk Quantum Bet – Analysis & Forecast (Updated November 16, 2025)

Updated: November 16, 2025Data snapshot: Prices and fundamentals referenced are as of the close on November 14, 2025, with news flow through the morning of November 16, 2025. Rigetti Computing (NASDAQ: RGTI) has gone from obscure micro‑cap to one of
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

CSCO Stock Today, Nov. 14, 2025 (After the Close): Cisco ends at $78.00 as fresh analyst targets and a Wells Fargo TMT Summit update keep AI-fueled rally in focus

Summary: Cisco Systems (NASDAQ: CSCO) finished Friday, November 14, 2025 at $78.00, up ~0.8% on the day, with shares holding near their post‑earnings highs as Wall Street continued to lift price targets and the company confirmed CFO Mark Patterson will
Rheinmetall Stock Slides Over 4% as F126 Frigate Deal Comes Under Pressure – Key Takeaways for 14 November 2025

Rheinmetall Stock Slides Over 4% as F126 Frigate Deal Comes Under Pressure – Key Takeaways for 14 November 2025

On Friday, 14 November 2025, shares in German defence group Rheinmetall AG (RHM) extended their recent correction, trading around €1,670–1,680 in Xetra by midday – a drop of roughly 4% versus Thursday’s close of €1,750.50 and around 16–17% below the early‑October record high of €2,008. DIE WELT+1
Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio, Inc. (NASDAQ: KRRO) is at the center of one of biotech’s biggest shake‑ups of 2025. After releasing mixed early data from its lead RNA‑editing program, KRRO‑110, the company has announced deep layoffs, a strategic pivot in its pipeline
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood Markets (HOOD) News Today — November 12, 2025: Wolfe Research Symposium Highlights, ‘Bull of the Day’ Nod, New Form 144 Filing, and Stock Action

Updated: November 12, 2025 At a Glance Wolfe Research appearance: strategy, growth vectors, and product road map Robinhood’s Steve Quirk spoke at Wolfe Research’s Wealth Symposium today (10:15 a.m. ET). The company had pre-announced the session and says a replay
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology (MU) Stock Today: Shares Edge Higher as New York Megafab Start Slips to 2026 — What It Means for Investors (Nov 12, 2025)

Micron (NASDAQ: MU) trades higher today after fresh filings confirmed its $100B New York megafab will begin construction in 2026 with first production targeted for 2030. Here’s the stock move, the headlines, and what to watch next. MU stock at
The Honest Company (HNST) — Today’s News (Nov. 12, 2025): Shares Rebound From 52‑Week Low as Analysts Scrutinize Earnings Quality and ‘Transformation 2.0’

The Honest Company (HNST) — Today’s News (Nov. 12, 2025): Shares Rebound From 52‑Week Low as Analysts Scrutinize Earnings Quality and ‘Transformation 2.0’

Shares of The Honest Company, Inc. (NASDAQ: HNST) bounced off last week’s lows on Wednesday as fresh commentary dissected the company’s cash‑flow quality and near‑term strategy following last week’s Q3 print and the launch of its “Transformation 2.0: Powering Honest
Viking Therapeutics (VKTX) Pops as Canaccord Nudges Price Target to $107; Stifel Conference Buzz & Fresh ObesityWeek® Data — Nov. 12, 2025

Viking Therapeutics (VKTX) Pops as Canaccord Nudges Price Target to $107; Stifel Conference Buzz & Fresh ObesityWeek® Data — Nov. 12, 2025

What’s new today (Nov. 12) Canaccord bumps target to $107. Before the open, Canaccord Genuity’s Edward Nash inched his VKTX target up by $1 to $107 and kept a Buy rating, framing Viking as a high‑quality obesity asset. The update
CoreWeave (CRWV) Q3 Earnings Today: 5 Things to Watch as AI Trade Wobbles — Revenue, RPO, Power Capacity, and Big‑Tech Deals

CoreWeave Stock Today (Nov 12, 2025): CRWV Slides After Guidance Cut; Data‑Center Delay and $55.6B Backlog Take Center Stage

Updated: Nov 12, 2025, 12:30 UTC Key takeaways CoreWeave stock price now As of 12:27 UTC, CoreWeave (NASDAQ: CRWV) was trading near $88, down roughly 16% on the day. (Intraday figures are based on live market data.) Early commentary across
Viking Therapeutics (VKTX) Rides Obesity Drug Wave: Stock Steadies as Analysts Eye Big Upside

Viking Therapeutics (VKTX) on Nov. 11, 2025: Stifel Fireside Chat Today, Fresh VK2735 Obesity Data From ObesityWeek, and Phase 3 VANQUISH Progress

Published: November 11, 2025 Viking Therapeutics, Inc. (NASDAQ: VKTX) steps into the spotlight today with a scheduled fireside chat at the Stifel 2025 Healthcare Conference in New York (4:40–5:10 p.m. ET). The appearance comes on the heels of new clinical
1 6 7 8 9 10 15
Go toTop